Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grégory Menchon

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Molecular Dynamics as a Tool for Virtual Ligand ScreeningGrégory Menchon, Laurent Maveyraud, Georges Czaplicki
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2018
Molecular Dynamics as a Tool for Virtual Ligand ScreeningGrégory Menchon, Laurent Maveyraud, Georges Czaplicki
Molecular Therapy. Nucleic Acids|February 3, 2026
Identification and functional validation of intracellular protein partners of phosphorothioate splice-switching oligonucleotides using AP-MSAris Gaci, Grégory Menchon, Johanna Bruce, et al.
ACS Omega|February 19, 2019
Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal StructureWolfgang Dohle, Andrea E Prota, Grégory Menchon, et al.
Molecular Therapy. Nucleic Acids|June 18, 2025
A genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanomaGrégory Menchon, Aris Gaci, Antti Matvere, et al.
Scientific Reports|March 12, 2016
Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV InterfaceGrégory Menchon, Oriane Bombarde, Mansi Trivedi, et al.
Nature Communications|May 31, 2018
A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulinGrégory Menchon, Andrea E Prota, Daniel Lucena-Agell, et al.
Journal of Medicinal Chemistry|December 12, 2017
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal StructureWolfgang Dohle, Fabrice L Jourdan, Grégory Menchon, et al.
Molecular Cell|July 4, 2020
Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing AgentMarco Jost, Yuwen Chen, Luke A Gilbert, et al.
Molecular Cell|October 7, 2017
Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing AgentMarco Jost, Yuwen Chen, Luke A Gilbert, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Molecular Dynamics as a Tool for Virtual Ligand ScreeningGrégory Menchon, Laurent Maveyraud, Georges Czaplicki
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2018
Molecular Dynamics as a Tool for Virtual Ligand ScreeningGrégory Menchon, Laurent Maveyraud, Georges Czaplicki
Molecular Therapy. Nucleic Acids|February 3, 2026
Identification and functional validation of intracellular protein partners of phosphorothioate splice-switching oligonucleotides using AP-MSAris Gaci, Grégory Menchon, Johanna Bruce, et al.
ACS Omega|February 19, 2019
Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal StructureWolfgang Dohle, Andrea E Prota, Grégory Menchon, et al.
Molecular Therapy. Nucleic Acids|June 18, 2025
A genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanomaGrégory Menchon, Aris Gaci, Antti Matvere, et al.
Scientific Reports|March 12, 2016
Structure-Based Virtual Ligand Screening on the XRCC4/DNA Ligase IV InterfaceGrégory Menchon, Oriane Bombarde, Mansi Trivedi, et al.
Nature Communications|May 31, 2018
A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulinGrégory Menchon, Andrea E Prota, Daniel Lucena-Agell, et al.
Journal of Medicinal Chemistry|December 12, 2017
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal StructureWolfgang Dohle, Fabrice L Jourdan, Grégory Menchon, et al.
Molecular Cell|July 4, 2020
Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing AgentMarco Jost, Yuwen Chen, Luke A Gilbert, et al.
Molecular Cell|October 7, 2017
Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing AgentMarco Jost, Yuwen Chen, Luke A Gilbert, et al.
Pageof 2